Angela Bryan
Concepts (469)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sexual Behavior | 40 | 2023 | 437 | 9.230 |
Why?
| Risk-Taking | 25 | 2023 | 319 | 7.230 |
Why?
| Adolescent Behavior | 24 | 2021 | 482 | 6.060 |
Why?
| Exercise | 31 | 2023 | 1657 | 5.520 |
Why?
| Condoms | 28 | 2021 | 110 | 5.460 |
Why?
| Sexually Transmitted Diseases | 17 | 2021 | 155 | 4.790 |
Why?
| Intention | 15 | 2021 | 142 | 4.470 |
Why?
| Juvenile Delinquency | 16 | 2016 | 103 | 4.460 |
Why?
| Alcohol Drinking | 25 | 2023 | 652 | 4.340 |
Why?
| Marijuana Smoking | 14 | 2021 | 220 | 3.820 |
Why?
| Marijuana Abuse | 14 | 2022 | 209 | 3.320 |
Why?
| Substance-Related Disorders | 16 | 2023 | 971 | 3.250 |
Why?
| Marijuana Use | 7 | 2021 | 157 | 3.040 |
Why?
| Motivation | 22 | 2023 | 506 | 2.950 |
Why?
| Risk Reduction Behavior | 8 | 2021 | 199 | 2.750 |
Why?
| Health Behavior | 17 | 2023 | 720 | 2.640 |
Why?
| Affect | 8 | 2020 | 240 | 2.530 |
Why?
| Attitude | 8 | 2021 | 231 | 2.520 |
Why?
| HIV Infections | 21 | 2023 | 2459 | 2.510 |
Why?
| Adolescent | 85 | 2023 | 18480 | 2.160 |
Why?
| Cannabis | 14 | 2023 | 382 | 1.970 |
Why?
| Unsafe Sex | 7 | 2018 | 57 | 1.930 |
Why?
| Brain | 17 | 2020 | 2490 | 1.920 |
Why?
| Health Promotion | 10 | 2023 | 691 | 1.840 |
Why?
| Self Efficacy | 11 | 2018 | 366 | 1.830 |
Why?
| Psychological Theory | 7 | 2021 | 96 | 1.800 |
Why?
| Health Knowledge, Attitudes, Practice | 11 | 2020 | 1185 | 1.770 |
Why?
| Cognition | 8 | 2023 | 1024 | 1.730 |
Why?
| Female | 126 | 2023 | 61564 | 1.710 |
Why?
| Male | 119 | 2023 | 57801 | 1.660 |
Why?
| Humans | 165 | 2023 | 118972 | 1.590 |
Why?
| Prisoners | 6 | 2018 | 128 | 1.590 |
Why?
| Sexual and Gender Minorities | 2 | 2023 | 137 | 1.530 |
Why?
| Young Adult | 49 | 2023 | 10793 | 1.430 |
Why?
| Safe Sex | 6 | 2020 | 18 | 1.390 |
Why?
| Hallucinogens | 8 | 2022 | 74 | 1.310 |
Why?
| Magnetic Resonance Imaging | 22 | 2021 | 3174 | 1.290 |
Why?
| Exercise Therapy | 5 | 2022 | 355 | 1.290 |
Why?
| Alcoholism | 13 | 2023 | 717 | 1.270 |
Why?
| Fruit | 2 | 2019 | 130 | 1.230 |
Why?
| Vegetables | 2 | 2019 | 133 | 1.230 |
Why?
| Adult | 73 | 2023 | 31512 | 1.200 |
Why?
| Body Mass Index | 7 | 2023 | 2092 | 1.150 |
Why?
| Attitude to Health | 6 | 2018 | 410 | 1.090 |
Why?
| Mindfulness | 3 | 2023 | 97 | 1.040 |
Why?
| Puberty | 2 | 2018 | 144 | 1.040 |
Why?
| Overweight | 3 | 2021 | 502 | 1.030 |
Why?
| Behavioral Medicine | 2 | 2023 | 43 | 1.020 |
Why?
| Feeding Behavior | 4 | 2019 | 601 | 1.020 |
Why?
| Decision Making | 5 | 2018 | 809 | 1.010 |
Why?
| Alcohol-Related Disorders | 6 | 2021 | 111 | 1.010 |
Why?
| Surveys and Questionnaires | 27 | 2021 | 4708 | 0.980 |
Why?
| Physical Fitness | 4 | 2020 | 179 | 0.960 |
Why?
| Brain Mapping | 6 | 2018 | 532 | 0.930 |
Why?
| DNA Methylation | 5 | 2018 | 503 | 0.910 |
Why?
| Health Education | 6 | 2009 | 318 | 0.910 |
Why?
| Underage Drinking | 3 | 2021 | 17 | 0.890 |
Why?
| Cues | 5 | 2019 | 297 | 0.870 |
Why?
| Reward | 5 | 2018 | 209 | 0.860 |
Why?
| Longitudinal Studies | 14 | 2021 | 2513 | 0.850 |
Why?
| Students | 11 | 2021 | 509 | 0.850 |
Why?
| Coitus | 2 | 2020 | 28 | 0.840 |
Why?
| Executive Function | 5 | 2020 | 391 | 0.830 |
Why?
| Smoking Cessation | 4 | 2017 | 360 | 0.820 |
Why?
| Behavior Therapy | 4 | 2023 | 237 | 0.810 |
Why?
| Medical Marijuana | 2 | 2020 | 102 | 0.790 |
Why?
| High-Intensity Interval Training | 1 | 2020 | 18 | 0.770 |
Why?
| Saliva | 2 | 2013 | 188 | 0.770 |
Why?
| Varenicline | 2 | 2017 | 21 | 0.770 |
Why?
| Homosexuality, Male | 3 | 2023 | 166 | 0.750 |
Why?
| Diet | 3 | 2023 | 1153 | 0.750 |
Why?
| Cannabinoids | 4 | 2022 | 115 | 0.750 |
Why?
| Attention | 3 | 2020 | 408 | 0.730 |
Why?
| Attentional Bias | 1 | 2019 | 10 | 0.720 |
Why?
| Parietal Lobe | 2 | 2019 | 42 | 0.710 |
Why?
| Sex Offenses | 2 | 2020 | 148 | 0.710 |
Why?
| Prisons | 2 | 2013 | 74 | 0.700 |
Why?
| Middle Aged | 35 | 2023 | 27617 | 0.690 |
Why?
| Irritable Bowel Syndrome | 1 | 2019 | 29 | 0.690 |
Why?
| Motivational Interviewing | 4 | 2023 | 84 | 0.680 |
Why?
| Delay Discounting | 2 | 2018 | 13 | 0.680 |
Why?
| Models, Psychological | 9 | 2018 | 298 | 0.670 |
Why?
| Sex Education | 2 | 2016 | 31 | 0.650 |
Why?
| Cocaine-Related Disorders | 1 | 2019 | 107 | 0.650 |
Why?
| Motor Activity | 2 | 2013 | 660 | 0.650 |
Why?
| Obesity | 5 | 2023 | 2746 | 0.640 |
Why?
| Reaction Time | 1 | 2019 | 392 | 0.640 |
Why?
| Limbic System | 1 | 2018 | 42 | 0.640 |
Why?
| Body Weight Maintenance | 1 | 2017 | 15 | 0.630 |
Why?
| Nerve Net | 2 | 2018 | 232 | 0.620 |
Why?
| RNA, Ribosomal, 16S | 1 | 2020 | 514 | 0.610 |
Why?
| Adolescent Development | 1 | 2018 | 84 | 0.610 |
Why?
| Homosexuality, Female | 2 | 2015 | 26 | 0.600 |
Why?
| Crime Victims | 2 | 2018 | 80 | 0.600 |
Why?
| Substance Withdrawal Syndrome | 1 | 2019 | 157 | 0.600 |
Why?
| Dronabinol | 7 | 2022 | 121 | 0.590 |
Why?
| Sequence Analysis, DNA | 1 | 2020 | 755 | 0.590 |
Why?
| Corpus Striatum | 1 | 2018 | 127 | 0.590 |
Why?
| Cerebral Cortex | 2 | 2018 | 416 | 0.590 |
Why?
| Aggression | 3 | 2015 | 183 | 0.580 |
Why?
| Smoking | 7 | 2017 | 1487 | 0.580 |
Why?
| Cannabidiol | 3 | 2022 | 53 | 0.580 |
Why?
| Tobacco Use Disorder | 2 | 2017 | 233 | 0.580 |
Why?
| Feedback, Psychological | 1 | 2016 | 20 | 0.560 |
Why?
| Genotype | 8 | 2014 | 1882 | 0.560 |
Why?
| Attention Deficit Disorder with Hyperactivity | 2 | 2017 | 366 | 0.560 |
Why?
| Cognitive Neuroscience | 1 | 2016 | 10 | 0.550 |
Why?
| Research Design | 5 | 2019 | 969 | 0.550 |
Why?
| Feeding and Eating Disorders | 2 | 2014 | 125 | 0.550 |
Why?
| Public Policy | 2 | 2015 | 62 | 0.550 |
Why?
| Follow-Up Studies | 12 | 2018 | 4596 | 0.550 |
Why?
| Video Games | 1 | 2016 | 22 | 0.550 |
Why?
| Risk Factors | 14 | 2017 | 9000 | 0.530 |
Why?
| Psychotherapy | 1 | 2017 | 177 | 0.530 |
Why?
| Sexual Partners | 2 | 2015 | 159 | 0.520 |
Why?
| Mental Disorders | 2 | 2019 | 939 | 0.520 |
Why?
| Temporal Lobe | 1 | 2015 | 90 | 0.520 |
Why?
| Criminals | 2 | 2014 | 31 | 0.510 |
Why?
| United States | 14 | 2021 | 12555 | 0.510 |
Why?
| Shame | 1 | 2014 | 11 | 0.510 |
Why?
| Coercion | 1 | 2014 | 11 | 0.510 |
Why?
| Body Image | 2 | 2014 | 72 | 0.500 |
Why?
| Brain-Derived Neurotrophic Factor | 3 | 2014 | 117 | 0.500 |
Why?
| Psychotherapy, Group | 3 | 2009 | 61 | 0.500 |
Why?
| Love | 2 | 2011 | 12 | 0.500 |
Why?
| Gymnastics | 1 | 2014 | 21 | 0.500 |
Why?
| Research Subjects | 1 | 2014 | 40 | 0.490 |
Why?
| Patient Dropouts | 1 | 2014 | 66 | 0.490 |
Why?
| Trust | 1 | 2015 | 113 | 0.490 |
Why?
| Criminal Law | 1 | 2014 | 26 | 0.490 |
Why?
| Self Report | 7 | 2021 | 699 | 0.490 |
Why?
| Oxygen Consumption | 3 | 2023 | 586 | 0.480 |
Why?
| Mental Health | 1 | 2019 | 568 | 0.470 |
Why?
| Mobile Applications | 1 | 2016 | 147 | 0.470 |
Why?
| Breast Neoplasms | 2 | 2017 | 1965 | 0.470 |
Why?
| Bacteria | 1 | 2020 | 757 | 0.460 |
Why?
| Biomedical Research | 1 | 2019 | 612 | 0.460 |
Why?
| Patient Compliance | 2 | 2014 | 537 | 0.460 |
Why?
| Program Evaluation | 4 | 2013 | 845 | 0.450 |
Why?
| Gastrointestinal Microbiome | 1 | 2020 | 548 | 0.450 |
Why?
| Task Performance and Analysis | 2 | 2015 | 164 | 0.440 |
Why?
| Heterosexuality | 3 | 2011 | 30 | 0.430 |
Why?
| Colorado | 11 | 2016 | 4196 | 0.430 |
Why?
| Social Norms | 3 | 2018 | 23 | 0.430 |
Why?
| Cross-Sectional Studies | 10 | 2021 | 4552 | 0.430 |
Why?
| Regression Analysis | 5 | 2016 | 983 | 0.430 |
Why?
| Flowers | 3 | 2022 | 56 | 0.430 |
Why?
| Weight Loss | 2 | 2021 | 655 | 0.420 |
Why?
| Substance Abuse Treatment Centers | 1 | 2012 | 42 | 0.410 |
Why?
| Cell Phone | 1 | 2012 | 81 | 0.410 |
Why?
| Biomarkers, Tumor | 1 | 2017 | 1059 | 0.400 |
Why?
| Courtship | 1 | 2011 | 11 | 0.400 |
Why?
| Peer Group | 3 | 2020 | 207 | 0.400 |
Why?
| Social Desirability | 1 | 2011 | 14 | 0.400 |
Why?
| Social Dominance | 1 | 2011 | 17 | 0.390 |
Why?
| Gray Matter | 3 | 2021 | 66 | 0.390 |
Why?
| Health Risk Behaviors | 2 | 2020 | 13 | 0.380 |
Why?
| Randomized Controlled Trials as Topic | 4 | 2023 | 1244 | 0.370 |
Why?
| Genomics | 2 | 2012 | 706 | 0.370 |
Why?
| Universities | 5 | 2020 | 347 | 0.360 |
Why?
| Receptors, Dopamine D2 | 3 | 2018 | 87 | 0.360 |
Why?
| Adaptation, Psychological | 1 | 2014 | 557 | 0.360 |
Why?
| Research | 3 | 2015 | 411 | 0.360 |
Why?
| Personal Satisfaction | 1 | 2011 | 188 | 0.350 |
Why?
| Phenotype | 6 | 2022 | 3003 | 0.340 |
Why?
| Psychotic Disorders | 2 | 2022 | 135 | 0.340 |
Why?
| White Matter | 2 | 2021 | 115 | 0.330 |
Why?
| Depressive Disorder, Major | 1 | 2012 | 303 | 0.330 |
Why?
| Impulsive Behavior | 5 | 2017 | 105 | 0.330 |
Why?
| Polymorphism, Single Nucleotide | 5 | 2014 | 2062 | 0.330 |
Why?
| Psychometrics | 6 | 2019 | 631 | 0.330 |
Why?
| Software | 1 | 2012 | 613 | 0.320 |
Why?
| Urban Population | 2 | 2009 | 409 | 0.320 |
Why?
| Aged | 10 | 2023 | 19657 | 0.310 |
Why?
| Interpersonal Relations | 1 | 2011 | 345 | 0.310 |
Why?
| Testosterone | 1 | 2011 | 351 | 0.310 |
Why?
| Models, Statistical | 2 | 2012 | 636 | 0.300 |
Why?
| Fatigue | 3 | 2016 | 297 | 0.300 |
Why?
| Antipsychotic Agents | 2 | 2022 | 193 | 0.300 |
Why?
| Individuality | 2 | 2009 | 147 | 0.300 |
Why?
| Prospective Studies | 5 | 2018 | 6471 | 0.290 |
Why?
| Treatment Outcome | 12 | 2022 | 9342 | 0.280 |
Why?
| Pilot Projects | 4 | 2022 | 1419 | 0.280 |
Why?
| Life Style | 3 | 2017 | 430 | 0.280 |
Why?
| Gender Identity | 2 | 2023 | 102 | 0.260 |
Why?
| Cluster Analysis | 2 | 2018 | 481 | 0.250 |
Why?
| Minority Health | 1 | 2023 | 20 | 0.240 |
Why?
| Depression | 1 | 2012 | 1132 | 0.230 |
Why?
| Physical Exertion | 3 | 2011 | 222 | 0.230 |
Why?
| Logistic Models | 2 | 2007 | 1901 | 0.230 |
Why?
| Reproducibility of Results | 10 | 2019 | 2874 | 0.230 |
Why?
| Sex Factors | 6 | 2019 | 1781 | 0.230 |
Why?
| Automobile Driving | 2 | 2007 | 128 | 0.220 |
Why?
| Body Weight | 2 | 2017 | 934 | 0.220 |
Why?
| Cooking | 1 | 2023 | 51 | 0.220 |
Why?
| Exercise Test | 2 | 2017 | 551 | 0.210 |
Why?
| Weight Lifting | 1 | 2002 | 30 | 0.210 |
Why?
| Effect Modifier, Epidemiologic | 1 | 2021 | 12 | 0.200 |
Why?
| Exploratory Behavior | 4 | 2015 | 90 | 0.200 |
Why?
| Tobacco Use | 2 | 2019 | 58 | 0.200 |
Why?
| Peer Influence | 1 | 2020 | 8 | 0.190 |
Why?
| Sexuality | 2 | 1997 | 18 | 0.190 |
Why?
| Ecological Momentary Assessment | 1 | 2020 | 25 | 0.190 |
Why?
| Appetite | 1 | 2020 | 57 | 0.190 |
Why?
| Sensation Disorders | 1 | 2020 | 33 | 0.190 |
Why?
| Occupations | 1 | 2000 | 37 | 0.180 |
Why?
| Analysis of Variance | 4 | 2011 | 1293 | 0.180 |
Why?
| Neuropsychological Tests | 4 | 2018 | 1032 | 0.180 |
Why?
| Socioeconomic Factors | 3 | 2015 | 1129 | 0.180 |
Why?
| Ethanol | 2 | 2021 | 575 | 0.180 |
Why?
| Heroin Dependence | 1 | 2000 | 19 | 0.180 |
Why?
| Occupational Diseases | 1 | 2001 | 136 | 0.180 |
Why?
| DNA, Ribosomal | 1 | 2020 | 79 | 0.180 |
Why?
| Receptors, Dopamine D4 | 3 | 2009 | 24 | 0.180 |
Why?
| CpG Islands | 2 | 2017 | 119 | 0.180 |
Why?
| Multivariate Analysis | 3 | 2012 | 1474 | 0.180 |
Why?
| Emotions | 2 | 2016 | 495 | 0.180 |
Why?
| Drug and Narcotic Control | 1 | 2019 | 28 | 0.180 |
Why?
| Migraine Disorders | 1 | 2020 | 79 | 0.180 |
Why?
| Diet Surveys | 1 | 2019 | 85 | 0.180 |
Why?
| Knowledge | 1 | 2019 | 59 | 0.180 |
Why?
| Methadone | 1 | 2000 | 69 | 0.170 |
Why?
| Cancer Survivors | 1 | 2023 | 201 | 0.170 |
Why?
| Self Concept | 2 | 2014 | 215 | 0.170 |
Why?
| Prevalence | 3 | 2018 | 2326 | 0.170 |
Why?
| Behavior, Addictive | 1 | 2019 | 77 | 0.170 |
Why?
| Statistics as Topic | 2 | 2012 | 307 | 0.170 |
Why?
| DNA, Bacterial | 1 | 2020 | 314 | 0.170 |
Why?
| Plant Extracts | 1 | 2020 | 165 | 0.160 |
Why?
| Hostility | 2 | 2015 | 13 | 0.160 |
Why?
| Chronic Pain | 1 | 2022 | 211 | 0.160 |
Why?
| Social Behavior | 2 | 2018 | 276 | 0.160 |
Why?
| Self Disclosure | 2 | 2009 | 60 | 0.160 |
Why?
| Age Factors | 4 | 2013 | 2995 | 0.160 |
Why?
| Taste | 2 | 2018 | 218 | 0.160 |
Why?
| Anger | 2 | 2015 | 59 | 0.160 |
Why?
| Patient Reported Outcome Measures | 1 | 2020 | 252 | 0.160 |
Why?
| Hyperkinesis | 1 | 2017 | 11 | 0.160 |
Why?
| Transcriptome | 1 | 2023 | 756 | 0.150 |
Why?
| Drinking | 1 | 2017 | 36 | 0.150 |
Why?
| Internal-External Control | 1 | 1997 | 68 | 0.150 |
Why?
| Alcoholic Beverages | 1 | 2017 | 17 | 0.150 |
Why?
| Self-Control | 1 | 2018 | 49 | 0.150 |
Why?
| Information Dissemination | 1 | 2019 | 210 | 0.150 |
Why?
| Cigarette Smoking | 1 | 2018 | 85 | 0.150 |
Why?
| Cannabinoid Receptor Agonists | 3 | 2021 | 30 | 0.150 |
Why?
| Single Person | 1 | 1996 | 6 | 0.150 |
Why?
| Heart Rate | 2 | 2013 | 729 | 0.150 |
Why?
| Prefrontal Cortex | 1 | 2019 | 275 | 0.140 |
Why?
| Psychiatric Status Rating Scales | 3 | 2014 | 499 | 0.140 |
Why?
| Nutrition Surveys | 1 | 2017 | 233 | 0.140 |
Why?
| Southwestern United States | 2 | 2017 | 94 | 0.140 |
Why?
| Nicotinic Agonists | 1 | 2017 | 110 | 0.140 |
Why?
| Cognitive Dysfunction | 1 | 2020 | 301 | 0.140 |
Why?
| Social Discrimination | 1 | 2015 | 11 | 0.140 |
Why?
| Nucleus Accumbens | 2 | 2015 | 131 | 0.130 |
Why?
| Social Justice | 1 | 2016 | 63 | 0.130 |
Why?
| Mental Recall | 1 | 2016 | 180 | 0.130 |
Why?
| Factor Analysis, Statistical | 4 | 2015 | 270 | 0.130 |
Why?
| Incidence | 2 | 2020 | 2424 | 0.130 |
Why?
| Neuroimaging | 1 | 2017 | 256 | 0.130 |
Why?
| Conduct Disorder | 1 | 2017 | 191 | 0.130 |
Why?
| Athletic Performance | 1 | 2015 | 46 | 0.130 |
Why?
| Sleep | 1 | 2020 | 660 | 0.130 |
Why?
| Genetic Predisposition to Disease | 1 | 2004 | 2275 | 0.130 |
Why?
| Goals | 1 | 2016 | 167 | 0.120 |
Why?
| Protective Factors | 1 | 2014 | 92 | 0.120 |
Why?
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2013 | 23 | 0.120 |
Why?
| Retinal Dehydrogenase | 1 | 2013 | 40 | 0.120 |
Why?
| Anisotropy | 1 | 2013 | 65 | 0.120 |
Why?
| Benzodiazepines | 1 | 2014 | 122 | 0.120 |
Why?
| Personality Inventory | 4 | 2011 | 134 | 0.120 |
Why?
| Diffusion Tensor Imaging | 1 | 2013 | 73 | 0.120 |
Why?
| Running | 1 | 2016 | 227 | 0.110 |
Why?
| India | 3 | 2007 | 141 | 0.110 |
Why?
| Models, Economic | 1 | 2013 | 48 | 0.110 |
Why?
| Nerve Fibers, Myelinated | 1 | 2013 | 46 | 0.110 |
Why?
| Body Temperature | 1 | 2013 | 215 | 0.110 |
Why?
| Norepinephrine | 1 | 2013 | 212 | 0.110 |
Why?
| Auditory Perception | 1 | 2013 | 106 | 0.110 |
Why?
| Visual Perception | 1 | 2013 | 141 | 0.110 |
Why?
| Microbiota | 1 | 2020 | 656 | 0.110 |
Why?
| Sex Characteristics | 2 | 2021 | 671 | 0.110 |
Why?
| Body Weights and Measures | 1 | 2012 | 35 | 0.110 |
Why?
| Artifacts | 1 | 2013 | 125 | 0.110 |
Why?
| Polymorphism, Genetic | 2 | 2008 | 642 | 0.110 |
Why?
| Comorbidity | 2 | 2012 | 1527 | 0.110 |
Why?
| Residential Treatment | 1 | 2012 | 31 | 0.110 |
Why?
| Lactic Acid | 1 | 2013 | 282 | 0.100 |
Why?
| Nursing Research | 1 | 2012 | 38 | 0.100 |
Why?
| Interview, Psychological | 1 | 2012 | 93 | 0.100 |
Why?
| Child | 5 | 2015 | 19129 | 0.100 |
Why?
| Receptor, Muscarinic M2 | 1 | 2011 | 8 | 0.100 |
Why?
| Speech | 1 | 2012 | 76 | 0.100 |
Why?
| Interviews as Topic | 2 | 2007 | 599 | 0.100 |
Why?
| Minnesota | 1 | 2012 | 137 | 0.100 |
Why?
| Secondary Prevention | 2 | 2023 | 227 | 0.100 |
Why?
| Sampling Studies | 1 | 2011 | 92 | 0.100 |
Why?
| Authoritarianism | 1 | 2011 | 9 | 0.100 |
Why?
| Beauty | 1 | 2011 | 12 | 0.100 |
Why?
| Genetic Markers | 1 | 2012 | 348 | 0.100 |
Why?
| Radiography | 1 | 2014 | 861 | 0.100 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2013 | 220 | 0.100 |
Why?
| Cost-Benefit Analysis | 1 | 2013 | 554 | 0.090 |
Why?
| Anorexia Nervosa | 1 | 2011 | 74 | 0.090 |
Why?
| Menstrual Cycle | 1 | 2011 | 113 | 0.090 |
Why?
| Connecticut | 2 | 2008 | 21 | 0.090 |
Why?
| Odorants | 1 | 2011 | 137 | 0.090 |
Why?
| Photic Stimulation | 2 | 2013 | 204 | 0.090 |
Why?
| Smell | 1 | 2011 | 118 | 0.090 |
Why?
| Cognition Disorders | 1 | 2014 | 529 | 0.090 |
Why?
| Forecasting | 1 | 2011 | 353 | 0.090 |
Why?
| Genome, Human | 1 | 2012 | 387 | 0.090 |
Why?
| Craving | 2 | 2023 | 33 | 0.090 |
Why?
| Genetic Variation | 2 | 2012 | 926 | 0.090 |
Why?
| Neoplasms | 1 | 2023 | 2179 | 0.090 |
Why?
| Psychotherapy, Brief | 1 | 2009 | 32 | 0.080 |
Why?
| Alcoholic Intoxication | 1 | 2009 | 63 | 0.080 |
Why?
| Pregnancy in Adolescence | 1 | 2009 | 77 | 0.080 |
Why?
| Recurrence | 1 | 2012 | 975 | 0.080 |
Why?
| Internet | 1 | 2013 | 633 | 0.080 |
Why?
| Biological Evolution | 1 | 2012 | 443 | 0.080 |
Why?
| Epigenesis, Genetic | 1 | 2012 | 539 | 0.080 |
Why?
| Biomarkers | 2 | 2021 | 3588 | 0.080 |
Why?
| Social Conformity | 1 | 2007 | 11 | 0.080 |
Why?
| Proteins | 1 | 2013 | 938 | 0.080 |
Why?
| Exons | 1 | 2008 | 307 | 0.080 |
Why?
| Aged, 80 and over | 1 | 2019 | 6561 | 0.080 |
Why?
| Computers | 1 | 2007 | 64 | 0.080 |
Why?
| Motor Vehicles | 1 | 2007 | 34 | 0.070 |
Why?
| Judgment | 1 | 2007 | 59 | 0.070 |
Why?
| Homoserine | 1 | 2006 | 6 | 0.070 |
Why?
| Minisatellite Repeats | 2 | 2008 | 38 | 0.070 |
Why?
| 4-Butyrolactone | 1 | 2006 | 19 | 0.070 |
Why?
| Blood Pressure | 1 | 2013 | 1664 | 0.070 |
Why?
| Body Temperature Regulation | 1 | 2007 | 73 | 0.070 |
Why?
| Adoption | 1 | 2006 | 38 | 0.070 |
Why?
| South Africa | 1 | 2006 | 163 | 0.070 |
Why?
| Hippocampus | 2 | 2022 | 735 | 0.070 |
Why?
| Reflex, Startle | 1 | 2005 | 63 | 0.070 |
Why?
| Acquired Immunodeficiency Syndrome | 1 | 2007 | 224 | 0.070 |
Why?
| Data Interpretation, Statistical | 1 | 2007 | 336 | 0.070 |
Why?
| Functional Neuroimaging | 2 | 2017 | 67 | 0.060 |
Why?
| Receptors, Nicotinic | 1 | 2007 | 295 | 0.060 |
Why?
| Pain | 1 | 2011 | 735 | 0.060 |
Why?
| Patient Education as Topic | 2 | 2009 | 699 | 0.060 |
Why?
| Aging | 1 | 2015 | 1670 | 0.060 |
Why?
| Calcium Signaling | 1 | 2006 | 219 | 0.060 |
Why?
| Social Perception | 1 | 2005 | 98 | 0.060 |
Why?
| Environment | 1 | 2006 | 346 | 0.060 |
Why?
| Risk | 1 | 2007 | 853 | 0.060 |
Why?
| Pseudomonas aeruginosa | 1 | 2006 | 305 | 0.060 |
Why?
| Food Preferences | 2 | 2017 | 119 | 0.060 |
Why?
| Habits | 1 | 2023 | 38 | 0.060 |
Why?
| Contraception Behavior | 2 | 2018 | 81 | 0.060 |
Why?
| New Mexico | 2 | 2014 | 67 | 0.060 |
Why?
| Time Factors | 2 | 2011 | 6412 | 0.050 |
Why?
| Child Behavior | 1 | 2004 | 212 | 0.050 |
Why?
| Genetics, Population | 1 | 2004 | 207 | 0.050 |
Why?
| Models, Theoretical | 2 | 2008 | 556 | 0.050 |
Why?
| Gene Frequency | 1 | 2004 | 513 | 0.050 |
Why?
| Chi-Square Distribution | 2 | 2009 | 525 | 0.050 |
Why?
| Risk Assessment | 1 | 2011 | 3057 | 0.050 |
Why?
| Smokers | 1 | 2023 | 149 | 0.050 |
Why?
| Quality of Life | 1 | 2012 | 2366 | 0.050 |
Why?
| Double-Blind Method | 2 | 2017 | 1687 | 0.050 |
Why?
| Exercise Tolerance | 1 | 2023 | 233 | 0.050 |
Why?
| Harm Reduction | 1 | 2021 | 25 | 0.050 |
Why?
| Pregnancy | 2 | 2012 | 5690 | 0.050 |
Why?
| Georgia | 1 | 2021 | 61 | 0.050 |
Why?
| Algorithms | 1 | 2008 | 1541 | 0.050 |
Why?
| Eating | 2 | 2014 | 369 | 0.050 |
Why?
| Psychomotor Disorders | 1 | 2020 | 18 | 0.050 |
Why?
| Models, Genetic | 1 | 2004 | 595 | 0.050 |
Why?
| Image Processing, Computer-Assisted | 2 | 2015 | 709 | 0.050 |
Why?
| Dose-Response Relationship, Drug | 2 | 2015 | 1945 | 0.050 |
Why?
| Verbal Learning | 1 | 2020 | 74 | 0.050 |
Why?
| Residence Characteristics | 1 | 2022 | 299 | 0.040 |
Why?
| Pain Management | 1 | 2022 | 294 | 0.040 |
Why?
| Spouses | 1 | 2000 | 88 | 0.040 |
Why?
| Substance Abuse, Intravenous | 1 | 2000 | 80 | 0.040 |
Why?
| Quality Indicators, Health Care | 1 | 2021 | 295 | 0.040 |
Why?
| Methylation | 1 | 2018 | 204 | 0.040 |
Why?
| Postural Balance | 1 | 2020 | 184 | 0.040 |
Why?
| Psychomotor Performance | 1 | 2020 | 290 | 0.040 |
Why?
| Achievement | 1 | 2018 | 58 | 0.040 |
Why?
| Guideline Adherence | 1 | 2022 | 523 | 0.040 |
Why?
| Tobacco Smoking | 1 | 2017 | 22 | 0.040 |
Why?
| Personality Assessment | 1 | 1997 | 78 | 0.040 |
Why?
| Benzazepines | 1 | 2017 | 38 | 0.040 |
Why?
| Social Adjustment | 1 | 2017 | 56 | 0.040 |
Why?
| Placebo Effect | 1 | 2017 | 52 | 0.040 |
Why?
| Beverages | 1 | 2017 | 70 | 0.040 |
Why?
| Organ Size | 1 | 2017 | 460 | 0.040 |
Why?
| Self-Assessment | 1 | 1996 | 63 | 0.040 |
Why?
| Case-Control Studies | 1 | 2004 | 3171 | 0.040 |
Why?
| Smoking Prevention | 2 | 2007 | 150 | 0.030 |
Why?
| Anticipation, Psychological | 1 | 2015 | 17 | 0.030 |
Why?
| Retrospective Studies | 3 | 2019 | 12978 | 0.030 |
Why?
| Pandemics | 1 | 2023 | 1355 | 0.030 |
Why?
| Analgesics, Opioid | 1 | 2022 | 794 | 0.030 |
Why?
| Drive | 1 | 2014 | 2 | 0.030 |
Why?
| Energy Intake | 1 | 2017 | 447 | 0.030 |
Why?
| Bulimia | 1 | 2014 | 26 | 0.030 |
Why?
| Event-Related Potentials, P300 | 1 | 2013 | 13 | 0.030 |
Why?
| Statistics, Nonparametric | 1 | 2015 | 403 | 0.030 |
Why?
| Drug Interactions | 1 | 2015 | 352 | 0.030 |
Why?
| Drug-Seeking Behavior | 1 | 2013 | 22 | 0.030 |
Why?
| Thinness | 1 | 2014 | 91 | 0.030 |
Why?
| Practice Patterns, Physicians' | 1 | 2022 | 1200 | 0.030 |
Why?
| Promoter Regions, Genetic | 1 | 2018 | 1158 | 0.030 |
Why?
| Evoked Potentials | 1 | 2013 | 115 | 0.030 |
Why?
| Wechsler Scales | 1 | 2012 | 57 | 0.030 |
Why?
| Quality Control | 1 | 2013 | 159 | 0.030 |
Why?
| Motion | 1 | 2013 | 95 | 0.030 |
Why?
| Acoustic Stimulation | 1 | 2013 | 321 | 0.030 |
Why?
| Personality | 1 | 2013 | 115 | 0.030 |
Why?
| Memory, Short-Term | 1 | 2014 | 233 | 0.030 |
Why?
| Life Change Events | 1 | 2012 | 134 | 0.030 |
Why?
| Image Enhancement | 1 | 2013 | 181 | 0.030 |
Why?
| Alleles | 1 | 2014 | 832 | 0.020 |
Why?
| Contraceptives, Oral | 1 | 2011 | 27 | 0.020 |
Why?
| Psychological Tests | 1 | 2011 | 129 | 0.020 |
Why?
| Respiratory Tract Diseases | 1 | 2012 | 143 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2018 | 2674 | 0.020 |
Why?
| Global Health | 1 | 2012 | 310 | 0.020 |
Why?
| Temperance | 1 | 2009 | 15 | 0.020 |
Why?
| Evidence-Based Medicine | 1 | 2013 | 693 | 0.020 |
Why?
| Genetic Association Studies | 1 | 2011 | 371 | 0.020 |
Why?
| Women's Health | 1 | 2011 | 274 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2013 | 1868 | 0.020 |
Why?
| Pain Measurement | 1 | 2011 | 469 | 0.020 |
Why?
| Activities of Daily Living | 1 | 2011 | 354 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2013 | 1795 | 0.020 |
Why?
| Precision Medicine | 1 | 2012 | 363 | 0.020 |
Why?
| Oxygen | 1 | 2012 | 854 | 0.020 |
Why?
| Administration, Cutaneous | 1 | 2007 | 119 | 0.020 |
Why?
| DNA Primers | 1 | 2008 | 533 | 0.020 |
Why?
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2006 | 26 | 0.020 |
Why?
| Patient Acceptance of Health Care | 1 | 2012 | 687 | 0.020 |
Why?
| Parents | 1 | 2014 | 1212 | 0.020 |
Why?
| NIH 3T3 Cells | 1 | 2006 | 139 | 0.020 |
Why?
| Homosexuality | 1 | 2006 | 16 | 0.020 |
Why?
| Cytosol | 1 | 2006 | 221 | 0.020 |
Why?
| Patient Satisfaction | 1 | 2009 | 610 | 0.020 |
Why?
| Twins, Dizygotic | 1 | 2006 | 182 | 0.020 |
Why?
| Stereotyping | 1 | 2005 | 37 | 0.020 |
Why?
| Social Values | 1 | 2005 | 38 | 0.020 |
Why?
| Virulence Factors | 1 | 2006 | 140 | 0.020 |
Why?
| Siblings | 1 | 2006 | 235 | 0.020 |
Why?
| Twins, Monozygotic | 1 | 2006 | 214 | 0.020 |
Why?
| Nicotine | 1 | 2007 | 276 | 0.020 |
Why?
| Endoplasmic Reticulum | 1 | 2006 | 241 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 982 | 0.020 |
Why?
| Binding Sites | 1 | 2007 | 1224 | 0.020 |
Why?
| Data Collection | 1 | 2007 | 658 | 0.020 |
Why?
| Age Distribution | 1 | 2004 | 362 | 0.010 |
Why?
| Sex Distribution | 1 | 2004 | 351 | 0.010 |
Why?
| Flow Cytometry | 1 | 2006 | 1085 | 0.010 |
Why?
| Parent-Child Relations | 1 | 2004 | 232 | 0.010 |
Why?
| Fibroblasts | 1 | 2006 | 842 | 0.010 |
Why?
| DNA | 1 | 2008 | 1388 | 0.010 |
Why?
| Endothelial Cells | 1 | 2006 | 732 | 0.010 |
Why?
| Animals | 2 | 2012 | 33381 | 0.010 |
Why?
| Gene Expression Regulation | 1 | 2007 | 2445 | 0.010 |
Why?
| Apoptosis | 1 | 2006 | 2484 | 0.010 |
Why?
| Inflammation | 1 | 2006 | 2566 | 0.010 |
Why?
| Cohort Studies | 1 | 2004 | 5116 | 0.010 |
Why?
| Mice | 1 | 2006 | 15520 | 0.010 |
Why?
|
|
Bryan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|